lifestyle.ukuncut.org.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
April 22, 2026
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
April 14, 2026
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
April 7, 2026
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
March 18, 2026
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
March 9, 2026
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
February 12, 2026